Puerarin mitigated LPS-ATP or HG-primed endothelial cells damage and diabetes-associated cardiovascular disease via ROS-NLRP3 signalling

J Cell Mol Med. 2024 May;28(10):e18239. doi: 10.1111/jcmm.18239.

Abstract

The occurrence and development of diabetic vascular diseases are closely linked to inflammation-induced endothelial dysfunction. Puerarin (Pue), the primary component of Pueraria lobata, possesses potent anti-inflammatory properties. However, its vasoprotective role remains elusive. Therefore, we investigated whether Pue can effectively protect against vascular damage induced by diabetes. In the study, Pue ameliorated lipopolysaccharide-adenosine triphosphate (LPS-ATP) or HG-primed cytotoxicity and apoptosis, while inhibited reactive oxygen species (ROS)-mediated NLR family pyrin domain containing 3 (NLRP3) inflammasome in HUVECs, as evidenced by significantly decreased ROS level, NOX4, Caspase-1 activity and expression of NLRP3, GSDMD, cleaved caspase-1, IL-1β and IL-18. Meanwhile, ROS inducer CoCI2 efficiently weakened the effects of Pue against LPS-ATP-primed pyroptosis. In addition, NLRP3 knockdown notably enhanced Pue's ability to suppress pyroptosis in LPS-ATP-primed HUVECs, whereas overexpression of NLRP3 reversed the inhibitory effects of Pue. Furthermore, Pue inhibited the expression of ROS and NLRP3 inflammasome-associated proteins on the aorta in type 2 diabetes mellitus rats. Our findings indicated that Pue might ameliorate LPS-ATP or HG-primed damage in HUVECs by inactivating the ROS-NLRP3 signalling pathway.

Keywords: Puerarin; ROS; diabetic vasculopathy; pyroptosis.

MeSH terms

  • Adenosine Triphosphate* / metabolism
  • Animals
  • Apoptosis / drug effects
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / metabolism
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / metabolism
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Glucose / metabolism
  • Human Umbilical Vein Endothelial Cells* / metabolism
  • Humans
  • Inflammasomes* / metabolism
  • Isoflavones* / pharmacology
  • Isoflavones* / therapeutic use
  • Lipopolysaccharides*
  • Male
  • NLR Family, Pyrin Domain-Containing 3 Protein* / metabolism
  • Pyroptosis / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species* / metabolism
  • Signal Transduction* / drug effects

Substances

  • puerarin